Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study

Published:2020-05-12 Issue:7 Volume:37 Page:3129-3148
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Kabadi Shaum M.,Near Aimee,Wada Keiko,Burudpakdee Chakkarin

Funder

AstraZeneca

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-020-01350-w.pdf

Reference39 articles.

1. American Cancer Society. Cancer facts & figures 2019. Atlanta: American Cancer Society; 2019.

2. Seymour EK, Ruterbusch JJ, Beebe-Dimmer JL, Schiffer CA. Real-world testing and treatment patterns in chronic lymphocytic leukemia: a SEER patterns of care analysis. Cancer. 2019;125(1):135–43.

3. Brenner H, Gondos A, Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood. 1980s;111(10):4916–21.

4. National Cancer Institute. Cancer stat facts: leukemia-chronic lymphocytic leukemia (CLL). 2020. https://seer.cancer.gov/statfacts/html/clyl.html. Accessed 10 Apr 2020.

5. Mato A, Jahnke J, Li P, et al. Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era. Haematologica. 2018;103:e0462.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience;Hematological Oncology;2023-02-17

2. The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019;BioMedical Engineering OnLine;2022-01-11

3. Correction to: Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study;Advances in Therapy;2020-06-13

4. AEs increase economic burden in patients with CLL;Reactions Weekly;2020-05

5. AEs increase economic burden in patients with CLL;PharmacoEconomics & Outcomes News;2020-05